Gamida Cell Ltd. - Ordinary Shares (GMDA) Social Stream



Gamida Cell Ltd. - Ordinary Shares (GMDA): $0.03

0.01 (-18.25%)

POWR Rating

Component Grades

Momentum

F

Stability

D

Sentiment

Quality

D

Add GMDA to Watchlist
Sign Up

Industry: Biotech

Industry

F

Ranked

#290 of 345

in industry

GAMIDA CELL LTD (GMDA) Price Targets From Analysts

The tables below show price targets and recommendations from analysts covering GAMIDA CELL LTD.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-11-01 4 $27 $11 $18.4 $0.295 6137.29%
2021-11-16 5 $22 $11 $15 $0.295 4984.75%
2022-03-24 5 $22 $11 $14.6 $0.295 4849.15%
2022-04-26 6 $22 $11 $14.6 $0.295 4849.15%
2022-08-02 6 $22 $6 $13.2 $0.295 4374.58%
2022-08-16 5 $22 $6 $13.2 $0.295 4374.58%
2022-09-12 5 $22 $8 $13.6 $0.295 4510.17%
2022-09-30 5 $22 $8 $13 $0.295 4306.78%
2022-10-02 5 $22 $7 $12.8 $0.295 4238.98%
2022-11-15 5 $22 $7 $13.25 $0.295 4391.53%
2022-11-22 5 $22 $7 $12 $0.295 3967.8%
2023-02-21 5 $22 $7 $11.75 $0.295 3883.05%
2023-04-18 5 $8 $5 $6.5 $0.295 2103.39%
2023-04-20 5 $11 $5 $7.5 $0.295 2442.37%
2023-05-15 4 $11 $5 $7.5 $0.295 2442.37%
2023-05-16 5 $11 $5 $7 $0.295 2272.88%
2023-05-22 5 $11 $5 $6.8 $0.295 2205.08%
2023-08-16 4 $11 $5 $7 $0.295 2272.88%
2023-11-15 4 $6 $2 $4.75 $0.295 1510.17%

The Trend in the Analyst Price Target


GMDA's average price target has moved down $9.85 over the prior 22 months.

Over the past 38 weeks, GMDA's average upside potential has been 440.14%.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2023-02-21 4 22 7 11.75 1.450 710.34%
2023-04-20 4 11 5 7.50 1.655 353.17%
2023-05-16 5 11 5 7.00 2.030 244.83%
2023-05-22 5 11 5 6.80 1.950 248.72%
2023-08-16 4 11 5 7.00 1.240 464.52%

GMDA Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1.25 3 1 0 0 0 4

The Trend in the Broker Recommendations


Over the past 43 months, GMDA's average broker recommendation rating worsened by 0.25.

The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.

  • To contextualize these metrics, consider that out of all US stocks, GAMIDA CELL LTD's upside potential (average analyst target price relative to current price) is higher than 1986.92% of them.
  • In the context of all US stocks, GAMIDA CELL LTD's average analyst price target is higher than 253.92% of them.
  • In the context of stocks in the small market cap category, GAMIDA CELL LTD's variance in analysts' estimates is lower than -1521.22% of them.
  • GMDA has a greater number of analysts covering the stock than 477.52% of Healthcare stocks.

Stocks similar to GAMIDA CELL LTD in the Pharmaceutical Products industry regarding analyst recommendations and price targets are IMTX, GRTS, and STRO.

Is GMDA a Buy, Hold or Sell? See the POWR Ratings now!


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!